<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ASGLT2_inhibitor%2F27%2Fen</id>
	<title>Translations:SGLT2 inhibitor/27/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3ASGLT2_inhibitor%2F27%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/27/en&amp;action=history"/>
	<updated>2026-08-25T00:42:01Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/27/en&amp;diff=113856&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/27/en&amp;diff=113856&amp;oldid=prev"/>
		<updated>2024-02-12T10:46:17Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Dapagliflozin disposition is not evidently affected by BMI or [[body weight]], therefore the pharmacokinetic findings are expected to be applicable to patients with a higher [[Body mass index|BMI]]. Dapagliflozin resulted in [[dose-dependent]] increases excretions in urinary glucose, up to 47g/d following single-dose administration, which can be expected from its [[mechanism of action]], dapagliflozin.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>